Warning (512): /home/pharma/website/current/cakephp/app/pharmalicensing/tmp/cache/ is not writable [CORE/cake/libs/cache/file.php, line 267]
Code
        if ($this->_init && !is_writable($this->settings['path'])) {
            $this->_init = false;
            trigger_error(sprintf(__('%s is not writable', true), $this->settings['path']), E_USER_WARNING);
FileEngine::__active() - CORE/cake/libs/cache/file.php, line 267
FileEngine::init() - CORE/cake/libs/cache/file.php, line 94
Cache::_buildEngine() - CORE/cake/libs/cache.php, line 151
Cache::config() - CORE/cake/libs/cache.php, line 126
include - /home/pharma/website/releases/20120317114903/cakephp/app/pharmalicensing/config/core.php, line 345
Configure::__loadBootstrap() - CORE/cake/libs/configure.php, line 391
Configure::getInstance() - CORE/cake/libs/configure.php, line 52
include - CORE/cake/bootstrap.php, line 38
[main] - /home/pharma/website/releases/20120317114903/cakephp/webroot/pharmalicensing/index.php, line 100

• Home
• Licensing Center
  • Data Center
    • Out-licensing
    • In-licensing
    • Companies
    • Services
  • Reports
  • Newsletter
    • Subscribe
    • Partnering Update
    • Key Reports
    • Pharmalicensing Recommends
  • Pharmalicensing Intelligence
    • Industry News
    • Deals Review
    • Press Releases
    • Articles
  • Profiled Companies
  • Events
• Our Services
  • Partnering Search
  • Company Profiling
  • Reports
  • Pharma Transfer
  • Deal Negotiation
  • Pharmalicensing Intelligence
• About us
  • Case Studies
  • Our Audience
  • FAQ
  • Directions
  • MedicalDeviceLicensing.com
  • Innovaro Corporate
• Contact us

Login    Register

Search

Industry news

• Industry news
• Financings
• News

CULS Conversion and Additional Listing

In order to access this content you must be logged in and have a subscription to Pharmalicensing Intelligence.

Pharmalicensing Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.

Subscribe now for instant access to the benefits Pharmalicensing Intelligence has to offer. Find out more.

Request a demo of
Pharmalicensing Intelligence

Company details

If you want to find out more about the company visit Alliance Pharma profile.

Related reports

Market Research Reports provided by reports.innovaro.com

How Britain Shops Clothing 2009

Jul 2009 - 117 pages - $4,795

How Britain Shops: Personal Care 2009

Jul 2009 - 93 pages - $4,795

UK Consumer Insights 2009: B&Q - DIY

Jul 2009 - 35 pages - $1,910

UK Consumer Insights 2009: Next - Clothing

Jul 2009 - 35 pages - $1,910

UK Consumer Insights 2009: Next - Footwear

Jul 2009 - 35 pages - $1,910

UK Consumer Insight 2010: New Look Footwear

Mar 2010 - 50 pages - $1,910

UK Consumer Insight 2010: Next Clothing

Mar 2010 - 50 pages - $1,910

UK Consumer Insights 2009: Comet - Electricals

Jul 2009 - 35 pages - $1,910

UK Consumer Insights 2009: Currys - Electricals

Jul 2009 - 35 pages - $1,910

UK Consumer Insight 2009: Matalan - Clothing

Jul 2009 - 35 pages - $1,910

More Related Market Research Reports >>>

Related news

Latest News

CULS Conversion and Additional Listing

Neuronetics selected by World Economic Forum as 2011 Technology Pioneer

Ferro Corporation Announces Expiration and Final Results of Tender Offer for its 6.50% Convertible Senior Notes Due 2013

PharmaGap Announces Closing of First Tranche of Private Placement

THERMOGENESIS ANNOUNCES REVERSE STOCK SPLIT EFFECTIVE ON NASDAQ CAPITAL MARKET AUGUST 27, 2010

Achillion Announces Private Placement of $50 Million

THERMOGENESIS ANNOUNCES STOCKHOLDER AUTHORIZATION OF REVERSE SPLIT

TetraLogic Pharmaceuticals COMPLETES $32 Million SERIES C FINANCING

PRO-DEX, INC. ANNOUNCES REVERSE STOCK SPLIT TO BE EFFECTIVE JUNE 18,2010

More news... | RSS Feed...

Most Viewed

CULS Conversion and Additional Listing

Neuronetics selected by World Economic Forum as 2011 Technology Pioneer

Ferro Corporation Announces Expiration and Final Results of Tender Offer for its 6.50% Convertible Senior Notes Due 2013

TetraLogic Pharmaceuticals COMPLETES $32 Million SERIES C FINANCING

Achillion Announces Private Placement of $50 Million

PharmaGap Announces Closing of First Tranche of Private Placement

THERMOGENESIS ANNOUNCES STOCKHOLDER AUTHORIZATION OF REVERSE SPLIT

THERMOGENESIS ANNOUNCES REVERSE STOCK SPLIT EFFECTIVE ON NASDAQ CAPITAL MARKET AUGUST 27, 2010

PRO-DEX, INC. ANNOUNCES REVERSE STOCK SPLIT TO BE EFFECTIVE JUNE 18,2010

Therapeutic Target

Cardiovascular

Dermatology

Endocrine and Metabolic

Gastroenterology

Genitourinary

Hematology

Immunology and Allergy

Infection

Musculoskeletal

Neurology

Obstetrics and Gynecology

Oncology

Ophthalmology

Psychiatry

Pulmonary

Categories

Deals and Alliances

Development

Financial Results

Financings

Intellectual Property

Regulatory

Press releases

Deals review

Headlines

PR Newswire

Products:	Partnering Search	Company Profiling	Pharmalicensing Intelligence	Reports	Comparision
In-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Out-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Companies:	Profiled companies	Industry Sector	Therapeutic Target	Geographic Location	Search	Add your company
Reports:	Biotechnology	Business Development	Management	Market & Sales	Medical Devices	Pharmaceuticals
News:	Deals & Alliances	Development	Financial Results	Financings	Intellectual Property	Regulatory
Events:	Pharma events	Calendar	Organizers	Featured events	Search
Articles:	Industrial Sector	Therapeutic Target	Articles date
Deals:	Industry Sector	Therapeutic Target	Deals Date	Search	Reports	Press releases
About us:	Our Audience	Case Studies	Newsletter	FAQ	Contact us	Site map

© Copyright 1998-2012 Innovaro Europe Ltd All rights reserved. Terms and Conditions | Contact us